You are here: Industry Insights > COVID-19

News List

Kantaro Receives FDA Emergency Use Authorization for Semi-Quantitative COVID-19 Antibody Test Kit that Detects the Presence and Level of SARS-CoV-2 IgG Antibodies prnewswire
November 26, 2020
Kantaro Biosciences, LLC, a joint venture between the Mount Sinai Health System and RenalytixAI, has received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) for COVID-SeroKlir, its semi-quantitative SARS-CoV-2 IgG ...
Co-Diagnostics JV CoSara Receives Clearance from Indian FDA for COVID-19 2-Gene Multiplex Test prnewswire
November 26, 2020
Co-Diagnostics, Inc., a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced that CoSara Diagnostics Pvt Ltd, its joint venture for manufacturing and sales in India, has received ...
One of the oldest vaccines could help combat COVID-19 europeanpharmaceuticalreview
November 26, 2020
Researchers have shown that recipients of the Bacillus Calmette-Guérin (BCG) vaccine are less likely to contract COVID-19 in a new study.
FDA Authorizes COVID-19 Test for Self-Testing at Home americanpharmaceuticalreview
November 26, 2020
The U.S. Food and Drug Administration (FDA) has issued an emergency use authorization (EUA) for the first COVID-19 diagnostic test for self-testing at home and provides rapid results.
RedHill Biopharma's Second COVID-19 Candidate Cleared by FDA for Phase 2/3 Study americanpharmaceuticalreview
November 26, 2020
RedHill Biopharma announced the U.S. Food and Drug Administration (FDA) has cleared the Company's Investigational New Drug (IND) application for a Phase 2/3 study evaluating orally administered RHB-107 (upamostat) in patients with symptomatic COVID-19 ...
Celltrion concludes enrolment for Phase II clinical trial of COVID-19 monoclonal treatment expresspharma
November 26, 2020
Celltrion anticipates submission for EUA to the Korean Ministry of Food and Drug Safety (MFDS), conditional on results from the global Phase II pivotal trial.
Clear Creek Bio doses first patient in phase 2 outpatient study of Brequinar to treat Covid-19 pharmaceutical-business-review
November 25, 2020
Clear Creek Bio, Inc. announced that the company has dosed the first patient in the CRISIS2 study, a Phase 2 clinical study evaluating brequinar for the treatment of Covid-19.
Over half of pharmacists report that COVID-19 has impacted their mental health pharmatimes
November 25, 2020
A new survey published by the Royal Pharmaceutical Society (RPS) in partnership with Pharmacist report has revealed the impact of COVID-19 on pharmacists’ mental health and wellbeing.
COVID-19 pandemic has emphasised existing health inequalities, research finds pharmatimes
November 25, 2020
Research conducted by Imperial College London in partnership with Philips UK has found that the COVID-19 pandemic has highlighted existing healthcare inequalities in the UK.
Lilly, Samsung Partner to Mass Produce COVID-19 Antibody americanpharmaceuticalreview
November 25, 2020
Samsung Biologics' partnership with Eli Lilly and Company is expected to accelerate the global supply for Lilly's COVID-19 antibody therapies through a long-term manufacturing agreement, with the goal of making antibody treatments more globally ...